InvestorsHub Logo
Followers 29
Posts 3145
Boards Moderated 0
Alias Born 03/14/2018

Re: None

Wednesday, 05/16/2018 1:55:18 PM

Wednesday, May 16, 2018 1:55:18 PM

Post# of 18666

GTBP has reported that it expects to file the Investigational New Drug Application (“IND”) for OXS-3550, the Company’s most advanced Tri-specific Killer Engager (“TriKE”) product candidate, in mid-2018.



That should make some big waves for $GTBP in investor land.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News